Chih-Rong Shyr, Ph.D.

2002 University of Rochester, Rochester, NY 
Molecular Biology, Cell Biology
"Chih-Rong Shyr"
Mean distance: 10177.7


Sign in to add mentor
Chawnshang Chang grad student 2002 Rochester
 (In vitro and in vivo analysis of the physiological roles of testicular receptor 2 (TR2) and testicular receptor 4 (TR4).)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Huang CP, Liu LX, Shyr CR. (2020) Tumor-associated Macrophages Facilitate Bladder Cancer Progression by Increasing Cell Growth, Migration, Invasion and Cytokine Expression. Anticancer Research. 40: 2715-2724
Huang CP, Chen CC, Tsai YT, et al. (2019) Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice. Cell Transplantation. 963689718822773
Huang CP, Chen CC, Shyr CR. (2018) Xenogeneic cell therapy provides a novel potential therapeutic option for cancers by restoring tissue function, repairing cancer wound and reviving anti-tumor immune responses. Cancer Cell International. 18: 9
Chen CC, Huang CP, Tsai YT, et al. (2017) The Genomic Alterations of 5α-Reductases and Their Inhibitor Finasteride's Effect in Bladder Cancer. Anticancer Research. 37: 6893-6898
Huang CP, Chen CC, Shyr CR. (2017) The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer. Cytotherapy
Chen CC, Huang CP, Hsieh TF, et al. (2016) Androgen receptor facilitates the recruitment of macrophages in tumor microenvironment to promote upper urinary tract urothelial cell carcinoma progression. American Journal of Cancer Research. 6: 1922-1934
Chen CC, Hsieh TF, Huang CP, et al. (2016) Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cells. American Journal of Cancer Research. 6: 238-48
Shang Z, Li Y, Zhang M, et al. (2015) Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9® enhances BCG efficacy to better suppress bladder cancer progression. Molecular Cancer Therapeutics
Huang CP, Hsieh TF, Chen CC, et al. (2014) Anabolic androgens affect the competitive interactions in cell migration and adhesion between normal mouse urothelial cells and urothelial carcinoma cells. Biochemical and Biophysical Research Communications. 452: 322-7
Chen L, Chang WC, Hung YC, et al. (2014) Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line. Reproductive Sciences (Thousand Oaks, Calif.). 21: 386-94
See more...